MHC IB-MEDIATED ISLET-ANTIGEN-SPECIFIC IMMUNOSUPPRESSION AS A NOVEL TREATMENT FOR TYPE 1 DIABETES

The present invention relates to therapeutical uses of non-classical human major histocompatibility complex (MHC) molecules (also named MHC class lb molecules) in combination with peptide antigens for the treatment of type 1 diabetes (T1D). The invention more specifically relates to recombinant poly...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	BRÜNNERT, Daniela, WISCHHUSEN, Jörg, AHSAN, Fadhil, BRUTTEL, Valentin
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!